The report indicates that the global market for drugs of abuse testing is forecast to grow at a 4.8% CAGR between 2013 and 2018. The market was worth US$2.6 billion in 2012, and assuming the CAGR holds true, the drugs of abuse testing market will be worth US$3.4 billion by 2018.
Albany, NY -- (SBWIRE) -- 11/19/2015 -- Globally, the drugs of abuse testing market is witnessing significant growth due to rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. As a result, this market is expected to grow at a CAGR of about 4.8% during 2013 – 2018.
Complete Report with TOC @ http://www.mrrse.com/drugs-abuse-testing-market
Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns.
North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population; cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, such as in America and Europe, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring.
Inquiry on this report @ http://www.mrrse.com/enquiry/885
In many countries, government rules & regulations are also supporting drugs of abuse testing market to grow, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market
Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about 5.0% during 2013 – 2018. Some of the other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives immediate results on the spot. It is generally preferred by those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only.
Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/885
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.